Fisher-pharyngeal-cervical-brachial overlap syndrome with novel ganglioside antibodies

Swetha Pedavally, Zulma M. Hernández, Lawrence A. Zeidman

Research output: Contribution to journalArticle

Abstract

Several variants of Guillain-Barré syndrome have been described. The Fisher syndrome (FS) presents with ataxia, areflexia, and ophthalmoparesis. The pharyngeal-cervical-brachial (PCB) variant presents with bulbar weakness, along with arm and neck weakness. The 2 variant syndromes can overlap. Both the isolated and overlap syndromes respond to immunomodulatory treatment, thus are important to recognize clinically. Ganglioside antibodies are detectable in the variant syndromes and may aid in their diagnosis. The FS typically is associated with anti-GQ1b antibodies, and PCB is typically associated with anti-GT1a antibodies, whereas the overlap syndrome may have both ganglioside antibody subtypes. We present a case of overlap FS-PCB syndrome with a novel ganglioside antibody profile of GM1 and GD1b antibodies, which typically are associated with other variant syndromes. This case suggests the need for all ganglioside antibodies to be tested in suspected variant Guillain-Barré syndromes. The antibodies may prove especially useful in cases in which the clinical diagnosis is ambiguous.

Original languageEnglish (US)
Pages (from-to)224-227
Number of pages4
JournalJournal of Clinical Neuromuscular Disease
Volume19
Issue number4
StatePublished - Jan 1 2018

Fingerprint

Gangliosides
Arm
Antibodies
Miller Fisher Syndrome
Anti-Idiotypic Antibodies
Ophthalmoplegia
Ataxia
Neck

Keywords

  • anti-GD1b IGM
  • Anti-GM1 IGM
  • Fisher syndrome
  • Guillain- Barré syndrome
  • Intravenous immunoglobulin
  • Miller Fisher syndrome
  • Pharyngeal-cervical-brachial variant Guillain-Barré syndrome

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Fisher-pharyngeal-cervical-brachial overlap syndrome with novel ganglioside antibodies. / Pedavally, Swetha; Hernández, Zulma M.; Zeidman, Lawrence A.

In: Journal of Clinical Neuromuscular Disease, Vol. 19, No. 4, 01.01.2018, p. 224-227.

Research output: Contribution to journalArticle

@article{fc20ec7f5b5849d4a54659bc3035971c,
title = "Fisher-pharyngeal-cervical-brachial overlap syndrome with novel ganglioside antibodies",
abstract = "Several variants of Guillain-Barr{\'e} syndrome have been described. The Fisher syndrome (FS) presents with ataxia, areflexia, and ophthalmoparesis. The pharyngeal-cervical-brachial (PCB) variant presents with bulbar weakness, along with arm and neck weakness. The 2 variant syndromes can overlap. Both the isolated and overlap syndromes respond to immunomodulatory treatment, thus are important to recognize clinically. Ganglioside antibodies are detectable in the variant syndromes and may aid in their diagnosis. The FS typically is associated with anti-GQ1b antibodies, and PCB is typically associated with anti-GT1a antibodies, whereas the overlap syndrome may have both ganglioside antibody subtypes. We present a case of overlap FS-PCB syndrome with a novel ganglioside antibody profile of GM1 and GD1b antibodies, which typically are associated with other variant syndromes. This case suggests the need for all ganglioside antibodies to be tested in suspected variant Guillain-Barr{\'e} syndromes. The antibodies may prove especially useful in cases in which the clinical diagnosis is ambiguous.",
keywords = "anti-GD1b IGM, Anti-GM1 IGM, Fisher syndrome, Guillain- Barr{\'e} syndrome, Intravenous immunoglobulin, Miller Fisher syndrome, Pharyngeal-cervical-brachial variant Guillain-Barr{\'e} syndrome",
author = "Swetha Pedavally and Hern{\'a}ndez, {Zulma M.} and Zeidman, {Lawrence A.}",
year = "2018",
month = "1",
day = "1",
language = "English (US)",
volume = "19",
pages = "224--227",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Fisher-pharyngeal-cervical-brachial overlap syndrome with novel ganglioside antibodies

AU - Pedavally, Swetha

AU - Hernández, Zulma M.

AU - Zeidman, Lawrence A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Several variants of Guillain-Barré syndrome have been described. The Fisher syndrome (FS) presents with ataxia, areflexia, and ophthalmoparesis. The pharyngeal-cervical-brachial (PCB) variant presents with bulbar weakness, along with arm and neck weakness. The 2 variant syndromes can overlap. Both the isolated and overlap syndromes respond to immunomodulatory treatment, thus are important to recognize clinically. Ganglioside antibodies are detectable in the variant syndromes and may aid in their diagnosis. The FS typically is associated with anti-GQ1b antibodies, and PCB is typically associated with anti-GT1a antibodies, whereas the overlap syndrome may have both ganglioside antibody subtypes. We present a case of overlap FS-PCB syndrome with a novel ganglioside antibody profile of GM1 and GD1b antibodies, which typically are associated with other variant syndromes. This case suggests the need for all ganglioside antibodies to be tested in suspected variant Guillain-Barré syndromes. The antibodies may prove especially useful in cases in which the clinical diagnosis is ambiguous.

AB - Several variants of Guillain-Barré syndrome have been described. The Fisher syndrome (FS) presents with ataxia, areflexia, and ophthalmoparesis. The pharyngeal-cervical-brachial (PCB) variant presents with bulbar weakness, along with arm and neck weakness. The 2 variant syndromes can overlap. Both the isolated and overlap syndromes respond to immunomodulatory treatment, thus are important to recognize clinically. Ganglioside antibodies are detectable in the variant syndromes and may aid in their diagnosis. The FS typically is associated with anti-GQ1b antibodies, and PCB is typically associated with anti-GT1a antibodies, whereas the overlap syndrome may have both ganglioside antibody subtypes. We present a case of overlap FS-PCB syndrome with a novel ganglioside antibody profile of GM1 and GD1b antibodies, which typically are associated with other variant syndromes. This case suggests the need for all ganglioside antibodies to be tested in suspected variant Guillain-Barré syndromes. The antibodies may prove especially useful in cases in which the clinical diagnosis is ambiguous.

KW - anti-GD1b IGM

KW - Anti-GM1 IGM

KW - Fisher syndrome

KW - Guillain- Barré syndrome

KW - Intravenous immunoglobulin

KW - Miller Fisher syndrome

KW - Pharyngeal-cervical-brachial variant Guillain-Barré syndrome

UR - http://www.scopus.com/inward/record.url?scp=85051834390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051834390&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 224

EP - 227

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 4

ER -